• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors.

作者信息

De Riese W T, De Riese C, Ulbright T M, Walker E B, Messemer J, Jones J A, Reister T, Albers P, Allhoff E P, Foster R S

机构信息

Department of Urology, Indiana University, Indianapolis.

出版信息

Int J Cancer. 1994 Jun 1;57(5):628-33. doi: 10.1002/ijc.2910570503.

DOI:10.1002/ijc.2910570503
PMID:8194868
Abstract

Our study was performed to clarify whether the combination of DNA flow-cytometric and quantitative histopathological parameters improves the prediction of occult metastatic disease in clinical stage-I non-seminomatous testicular germ-cell tumors (NSGCT). We used archival paraffin primary-tumor tissue of 67 clinical stage-I NSGCT patients who had undergone retroperitoneal lymph-node dissection (RPLND). According to the RPLND specimens, 24 patients were at pathological stage I and 43 at pathological stage II. Archival blocks were redissected for histological re-evaluation. In addition, 50 microns sections were prepared according to the Hedley technique in order to obtain nuclear suspensions which were processed for flow cytometry (FC). In univariate analysis, the percentage of embryonal carcinoma, the percentage of immature teratoma and vascular invasion were the most accurate predictive histopathological parameters. The percentage of aneuploid cells in S-phase was the best predictive FC parameter. In multivariate analysis, the percentage of embryonal carcinoma and the S-phase fraction of aneuploid cells were the only independent markers for occult metastatic disease. According to this statistical approach, 91.0% of pathological stage-I and stage-II cases were correctly classified. Sensitivity was 95.3% and specificity was 83.3%. Using histopathological criteria alone, only 56.7% NSGCT patients were correctly classified.

摘要

相似文献

1
Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors.
Int J Cancer. 1994 Jun 1;57(5):628-33. doi: 10.1002/ijc.2910570503.
2
Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors.
Urol Res. 1994;22(4):213-20. doi: 10.1007/BF00541895.
3
Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.用于预测临床I期非精原细胞瘤性睾丸生殖细胞肿瘤隐匿性疾病的流式细胞术和定量组织学参数。
J Urol. 1993 Sep;150(3):879-83. doi: 10.1016/s0022-5347(17)35638-0.
4
Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.可识别处于临床I期非精原细胞瘤性生殖细胞肿瘤且发生转移低风险和高风险患者的预后风险因素。
Cancer. 1998 Sep 1;83(5):1002-11.
5
Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
Cancer. 1995 Feb 1;75(3):844-50. doi: 10.1002/1097-0142(19950201)75:3<844::aid-cncr2820750316>3.0.co;2-c.
6
Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.
Cancer Res. 1994 Jan 15;54(2):362-4.
7
Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors.
Cancer. 1994 Aug 15;74(4):1335-41. doi: 10.1002/1097-0142(19940815)74:4<1335::aid-cncr2820740425>3.0.co;2-t.
8
Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors.
J Urol. 1997 Aug;158(2):620-5.
9
alpha-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer.
BJU Int. 2002 Feb;89(3):278-84. doi: 10.1046/j.1464-4096.2001.2417.x.
10
Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.
J Urol. 1994 Oct;152(4):1133-8. doi: 10.1016/s0022-5347(17)32522-3.

引用本文的文献

1
Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.睾丸临床I期非精原细胞性生殖细胞肿瘤患者的风险适应性管理。
Med Oncol. 2009;26(2):136-42. doi: 10.1007/s12032-008-9095-6. Epub 2008 Sep 26.
2
Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors.临床I期非精原细胞瘤性睾丸肿瘤管理中的成本与风险效益考量
Ann Surg Oncol. 1996 Jan;3(1):86-93. doi: 10.1007/BF02409057.